5zhp

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (05:00, 21 November 2024) (edit) (undo)
 
(2 intermediate revisions not shown.)
Line 1: Line 1:
-
'''Unreleased structure'''
 
-
The entry 5zhp is ON HOLD until Paper Publication
+
==M3 muscarinic acetylcholine receptor in complex with a selective antagonist==
 +
<StructureSection load='5zhp' size='340' side='right'caption='[[5zhp]], [[Resolution|resolution]] 3.10&Aring;' scene=''>
 +
== Structural highlights ==
 +
<table><tr><td colspan='2'>[[5zhp]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Escherichia_virus_T4 Escherichia virus T4] and [https://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5ZHP OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5ZHP FirstGlance]. <br>
 +
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.1&#8491;</td></tr>
 +
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=9EC:(1R,2R,4S,5S,7s)-7-({[4-fluoro-2-(thiophen-2-yl)phenyl]carbamoyl}oxy)-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]nonan-9-ium'>9EC</scene>, <scene name='pdbligand=CIT:CITRIC+ACID'>CIT</scene>, <scene name='pdbligand=GLC:ALPHA-D-GLUCOSE'>GLC</scene>, <scene name='pdbligand=P6G:HEXAETHYLENE+GLYCOL'>P6G</scene>, <scene name='pdbligand=PG4:TETRAETHYLENE+GLYCOL'>PG4</scene></td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5zhp FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5zhp OCA], [https://pdbe.org/5zhp PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5zhp RCSB], [https://www.ebi.ac.uk/pdbsum/5zhp PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5zhp ProSAT]</span></td></tr>
 +
</table>
 +
== Function ==
 +
[https://www.uniprot.org/uniprot/ENLYS_BPT4 ENLYS_BPT4] Endolysin with lysozyme activity that degrades host peptidoglycans and participates with the holin and spanin proteins in the sequential events which lead to the programmed host cell lysis releasing the mature viral particles. Once the holin has permeabilized the host cell membrane, the endolysin can reach the periplasm and break down the peptidoglycan layer.<ref>PMID:22389108</ref> [https://www.uniprot.org/uniprot/ACM3_RAT ACM3_RAT] The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is Pi turnover.<ref>PMID:1527051</ref> <ref>PMID:1657592</ref> <ref>PMID:22358844</ref>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
Drugs that treat chronic obstructive pulmonary disease by antagonizing the M3 muscarinic acetylcholine receptor (M3R) have had a significant effect on health, but can suffer from their lack of selectivity against the M2R subtype, which modulates heart rate. Beginning with the crystal structures of M2R and M3R, we exploited a single amino acid difference in their orthosteric binding pockets using molecular docking and structure-based design. The resulting M3R antagonists had up to 100-fold selectivity over M2R in affinity and over 1,000-fold selectivity in vivo. The crystal structure of the M3R-selective antagonist in complex with M3R corresponded closely to the docking-predicted geometry, providing a template for further optimization.
-
Authors:
+
Structure-guided development of selective M3 muscarinic acetylcholine receptor antagonists.,Liu H, Hofmann J, Fish I, Schaake B, Eitel K, Bartuschat A, Kaindl J, Rampp H, Banerjee A, Hubner H, Clark MJ, Vincent SG, Fisher JT, Heinrich MR, Hirata K, Liu X, Sunahara RK, Shoichet BK, Kobilka BK, Gmeiner P Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):12046-12050. doi:, 10.1073/pnas.1813988115. Epub 2018 Nov 7. PMID:30404914<ref>PMID:30404914</ref>
-
Description:
+
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
-
[[Category: Unreleased Structures]]
+
</div>
 +
<div class="pdbe-citations 5zhp" style="background-color:#fffaf0;"></div>
 +
 
 +
==See Also==
 +
*[[Muscarinic acetylcholine receptor|Muscarinic acetylcholine receptor]]
 +
== References ==
 +
<references/>
 +
__TOC__
 +
</StructureSection>
 +
[[Category: Escherichia virus T4]]
 +
[[Category: Large Structures]]
 +
[[Category: Rattus norvegicus]]
 +
[[Category: Banerjee A]]
 +
[[Category: Bartuschat A]]
 +
[[Category: Clark MJ]]
 +
[[Category: Eitel K]]
 +
[[Category: Fish I]]
 +
[[Category: Fisher J]]
 +
[[Category: Gmeiner P]]
 +
[[Category: Heinrich M]]
 +
[[Category: Hirata K]]
 +
[[Category: Hofmann J]]
 +
[[Category: Hubner H]]
 +
[[Category: Kaindl J]]
 +
[[Category: Kobilka BK]]
 +
[[Category: Liu H]]
 +
[[Category: Liu X]]
 +
[[Category: Rampp H]]
 +
[[Category: Schaake B]]
 +
[[Category: Shoichet BK]]
 +
[[Category: Sunahara RK]]
 +
[[Category: Vincent SG]]

Current revision

M3 muscarinic acetylcholine receptor in complex with a selective antagonist

PDB ID 5zhp

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools